Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Annexon | ANNX | Apr 17, 2025 | 1.46 | +2.10 |
Annovis Bio | ANVS | Apr 17, 2025 | 1.22 | -3.17 |
ANSYS | ANSS | Apr 17, 2025 | 302.74 | +0.38 |
Antelope Enterprise | AEHL | Apr 17, 2025 | 2.70 | -6.25 |
Anteris Technologies Global | AVR | Apr 17, 2025 | 2.88 | +0.88 |
Anterix | ATEX | Apr 17, 2025 | 32.58 | +0.84 |
Antero Midstream | AM | Apr 17, 2025 | 17.18 | +1.90 |
Antero Resources | AR | Apr 17, 2025 | 34.42 | +0.35 |
Anywhere Real Estate | HOUS | Apr 17, 2025 | 2.97 | -1.00 |
Aon | AON | Apr 17, 2025 | 367.41 | -1.45 |
APA | APA | Apr 17, 2025 | 16.11 | +4.81 |
Apartment Investment and Management | AIV | Apr 17, 2025 | 7.83 | +2.09 |
Apellis Pharmaceuticals | APLS | Apr 17, 2025 | 18.20 | +0.22 |
APi Group | APG | Apr 17, 2025 | 34.79 | +1.08 |
Apogee Enterprises | APOG | Apr 17, 2025 | 45.54 | -0.37 |
Apogee Therapeutics | APGE | Apr 17, 2025 | 33.11 | +3.34 |
Apollo Commercial Real Estate Finance | ARI | Apr 17, 2025 | 8.35 | +2.20 |
Apollo Global Management | APO | Apr 17, 2025 | 126.78 | +1.25 |
Apollomics | APLM | Apr 17, 2025 | 5.95 | +1.02 |
AppFolio A | APPF | Apr 17, 2025 | 218.78 | +0.39 |
Appian A | APPN | Apr 17, 2025 | 26.55 | -1.37 |
Apple | AAPL | Apr 17, 2025 | 196.98 | +1.40 |
Apple Hospitality REIT | APLE | Apr 17, 2025 | 11.88 | +3.13 |
Applied Digital | APLD | Apr 17, 2025 | 3.95 | -3.19 |
Applied DNA Sciences | APDN | Apr 17, 2025 | 0.81 | +1.38 |
Applied Industrial Technologies | AIT | Apr 17, 2025 | 221.75 | +2.90 |
Applied Materials | AMAT | Apr 17, 2025 | 137.46 | -0.53 |
Applied Optoelectronics | AAOI | Apr 17, 2025 | 10.66 | +2.21 |
Applied Therapeutics | APLT | Apr 17, 2025 | 0.33 | +9.61 |
Applovin A | APP | Apr 17, 2025 | 238.22 | +3.66 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.